Evidence map›Paper›PMID 41217821›Full record

ArticleJCI insight2025

Bronchial epithelial transcriptome reveals dysregulated interferon and inflammatory responses to rhinovirus in exacerbation-prone pediatric asthma.

Naresh Doni Jayavelu, Basilin Benson, Patricia C Dela Cruz, Weston T Powell, Lucille M Rich, Elizabeth R Vanderwall, Camile R Gates, Andrew J Nagel, Maria P White, Nyssa B Samanas and 5 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Distinct epithelial and antiviral airway states in pediatric refractory asthma and rhinovirus-associated exacerbation.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  3. Article
  4. Contemporary Concise Review 2025: Asthma.Respirology (Carlton, Vic.) · 2026
    Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Naresh Doni JayaveluSystems Immunology Division, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Basilin BensonSystems Immunology Division, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Patricia C Dela CruzCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.
Weston T PowellCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.
Lucille M RichCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.
Elizabeth R VanderwallCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.
Camile R GatesCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.
Andrew J NagelDivision of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, USA.
Maria P WhiteCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.
Nyssa B SamanasCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.
Kourtnie WhitfieldSchool of Biological Sciences, Washington State University, Pullman, Washington, USA.
Teal S HallstrandCenter for Lung Biology, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, Washington, USA.
Steven F ZieglerSystems Immunology Division, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Matthew C AltmanSystems Immunology Division, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Jason S DebleyCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.

Funding

Childhood Asthma in Urban Settings Leadership Center Administrative Supplement for URECA Yr4UM1AI160040 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI James E. Gern, DANIEL J JACKSON · 2021 to 2026
$41.1M
The Bioinformatics and Data Management Core (BDMC)U19AI175089 · NIAID · UNIVERSITY OF WASHINGTON · PI JASON S DEBLEY, Teal S Hallstrand · 2023 to 2026
$7.8M
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodelingR01AI163160 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI JASON S DEBLEY · 2022 to 2026
$4.3M
Impact of Heterogeneous Airway Epithelial ACE2 Expression and Interferon Responses on SARS-CoV2 Infectivity and ReplicationK24AI150991 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI DEBLEY, JASON S · 2020 to 2024
$1.2M
Circadian Regulation of Epithelial Immune Reponses in AsthmaK08HL179396 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI Weston Thomas Powell · 2025 to 2026
$310k
NHLBI NIH HHS K08 HL179396NIAID NIH HHS K24 AI150991NIAID NIH HHS R01 AI163160NIAID NIH HHS U19 AI175089NIAID NIH HHS UM1 AI160040
6 · The paper itself

Abstract

Host factors influencing susceptibility to rhinovirus-induced asthma exacerbations remain poorly characterized. Using organotypic bronchial epithelial cultures from well-characterized children with asthma and healthy children, this study investigated viral load kinetics and resultant host responses by bulk and single-cell transcriptomics and targeted protein analyses. Bronchial epithelium from exacerbation-prone children exhibited greater rhinovirus replication and a cascade of exaggerated downstream interferon (IFN), inflammatory, epithelial stress, and remodeling responses. These transcriptional patterns were confirmed and further refined using single-cell transcriptomics, revealing cell type-specific contributions - particularly from non-ciliated cell populations including secretory immune response, tuft, and basal cells. We observed that these post-infection differences were associated with lower pre-infection IFN-stimulated gene (ISG) expression and protein levels of the ISG CXCL10. Prophylactic IFN-β treatment reduced viral replication and normalized downstream responses, supporting low baseline (pre-infection) IFN tone as a modifiable causal determinant of host susceptibility to adverse rhinovirus-induced responses in exacerbation-prone children with asthma.

Indexed as

AsthmaBronchiInterferonsPicornaviridae InfectionsRespiratory MucosaRhinovirusTranscriptomeAdolescentChemokine CXCL10ChildChild, PreschoolEpithelial CellsFemaleHumansInflammationInterferon-betaChemokine CXCL10CXCL10 protein, humanInterferon-betaInterferonsAsthmaCell biologyImmunologyPulmonology

Identifiers

PMID41217821
PMCPMC12890530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.